This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Martin H. Teicher, MD, PhD; Ross J. Baldessarini, MD
Mailman Research Center McLean Hospital 115 Mill St Belmont, MA 02178

Arch Gen Psychiatry. 1985;42(6):636-637.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

There continues to be a lack of quantitative data to guide the selection of appropriate doses of neuroleptic agents. Such information would be particularly useful for longterm treatment of chronically psychotic patients to minimize the risk of

Dose-Effect Relationship for Fluphenazine Decanoate in the Treatment of Schizophrenia for One Year Study, yr Dosage Mean No. of Range, Dosage, Relapse Dropout Success Subjects mg/2 wk mg/2 wk* Rate, % Rate, % Rate, % Hogarty et al, 1 1979 55 12.5-125 41 35.1 Marder et al, 2 1984 22 25-50 36 20.2 22.7 62 Rifkin et al, 3 1977 19 12.5-50 31 5.3 42.1 53 Kane et al, 4,5 1983, 1984 64 12.5-50 31 7.0 Marder et al, 2 1984 28 5-10 22.4 7.1 72 Kane et al, 5 1984 36 2.5-10 20.0 Kane et al, 4, 5 1983, 1984 62 1.25-5 56.0 Hogarty et al, 6 1976 41 67.4 4.7 32 Rifkin et al, 3 1977 19 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?